Author:
El Ekiaby Magdy,Lelie Nico,Allain Jean-Pierre
Subject
Pharmacology,General Immunology and Microbiology,Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology
Reference32 articles.
1. HIV antibody screening remains indispensable for ensuring viral safety of blood components despite NAT implementation;Laperche;Transfusion,2003
2. Postma MJ, Bos JM, van Hulst M. Pharmaco-economics of nucleic-acid amplification testing (NAT) of Dutch blood donors for HIV. International Conference on AIDS, 2002; 14: abstract no. TuPeC4861.
3. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing;Stramer;New Engl Med,2004
4. van Hulst M, Sagoe KW, Vermande JE, van der Schaaf IP, van der Tuuk Adriani WP. Cost-effectiveness of HIV screening of blood donations in Accra (Ghana). In: Health economics of blood transfusion safety. Rijksuniversiteit Groningen, Netherlands; 2008.
5. Recommendations;Screening Blood Donations for Transfusion-Transmissible Infections;World Health Organization,2009
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献